The Myelin Repair Foundation (MRF), a research nonprofit organization dedicated to the discovery and development of myelin repair therapeutics for multiple sclerosis (MS), today announced the appointment of Dr. Ted Yednock, Ph.D. to its Drug Discovery Advisory Board. Most recently the Executive Vice President, Head of Research at Elan Pharmaceuticals and inventor of the Tysabri antibody, Dr. Yednock joins the Drug Discovery Advisory Board at the MRF to bring top industry expertise in developing therapeutics for MS patients.
Help employers find you! Check out all the jobs and post your resume.
